Looking at 2 Antimicrobials for Drug-Resistant Pseudomonas aeruginosa

The purpose of this review is to discuss the in vitro activity and real-world evidence of ceftolozane-tazobactam ...

FEBRUARY 26, 2025

New Guidance for AMR Gram-Negative Infections

The Infectious Diseases Society of America recently updated guidance for the treatment of antimicrobial-resistant ...

AUGUST 23, 2024

Early Avycaz Therapy Increases Success Rates for MDR P. aeruginosa Pneumonia

Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa is a prevalent and ...

AUGUST 28, 2023

Right Drug for the HABP and VABP Patient

Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia are among the most common and ...

AUGUST 23, 2023

Take Advantage of Newer Antibiotic Options

Antibiotic-resistant infections and deaths increased by 15% during the pandemic, according to the Infectious ...

OCTOBER 13, 2022

The ‘Perfect Storm’ That Hampers Stewardship

Antimicrobial resistance continues to present a challenge to patient care for gram-negative bacterial infections, ...

NOVEMBER 14, 2017

Resistance to Colistin Low, but Geographically Dispersed

While Colistin still is very effective at eliminating CRE, resistance has been found to be spread across the ...

JUNE 22, 2017